Format

Send to

Choose Destination
  • Filters activated: Field: Title Word. Clear all
Pharm Res. 2011 Dec;28(12):3030-42. doi: 10.1007/s11095-011-0548-9. Epub 2011 Aug 31.

MicroRNA replacement therapy for cancer.

Author information

1
College of Pharmacy, Ohio State University, Columbus, Ohio, USA.

Abstract

MicroRNA are small noncoding RNAs that translationally repress their target messenger RNAs. Many microRNAs are expressed at reduced levels in tumors. microRNAs with reduced expression in cancer often regulate oncogenes, resulting in enhanced tumor growth. One therapeutic option is to restore microRNA levels in the tumor to that of the non-diseased tissue. This is possible by delivering microRNA to the tumor in the form of an oligonucleotide mimic or by expressing the microRNA in the cancer using a gene vector. This article surveys the field of oligonucleotide mimics and gene vector approaches to restore microRNA levels in tumors and reviews the literature on experimental and pre-clinical studies that have used these approaches to treat cancer.

PMID:
21879389
DOI:
10.1007/s11095-011-0548-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center